secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cullinan Therapeutics, Inc. (CGEM)
CIK:        0001789972
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0000950170-24-078554
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cullinan Therapeutics stockholders elect Anne-Marie Martin and David Meek as directors, ratify KPMG as auditor
--------------------------------------------------------------------------------

- Anne-Marie Martin elected with 25,054,060 votes for, 11,471,277 withheld, 4,156,894 broker non-votes.
- David Meek elected with 36,409,849 votes for, 115,488 withheld, 4,156,894 broker non-votes.
- KPMG LLP ratified as independent auditor for FY2024 with 40,163,993 for, 516,975 against, 1,263 abstentions.
- Annual meeting held June 26, 2024; no other proposals were considered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1789972/000095017024078554/0000950170-24-078554-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1789972/000095017024078554/cgem-20240626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-078554

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer